Biography - Dr David Haywood
David Haywood received his BSc and PhD degrees from the
University of Kent at Canterbury, and carried out post-doctoral
work in synthetic photochemistry at the University of London,
before joining Glaxo as a development chemist in 1980.
He worked on a number of projects in the
Chemical Development department before transferring to the Glaxo
manufacturing organisation in Montrose, Scotland as a Section Head
with world wide technical responsibility for a number of commercial
products in 1990.
In 1993 he moved to Singapore to manage the
plant and process commissioning of the new multi-purpose facility
at Glaxo’s site. Upon completion of this work he moved back
to the UK and became Technical Department Head at Glaxo’s
cephalosporin manufacturing facility in Ulverston, Cumbria.
Following the merger with Welcome, he also
took on responsibility for the technical department based at
Welcome’s Dartford site for the Outsourcing group which had the
responsibility for identifying, and carrying out technology
transfer to external suppliers of intermediates and Bulk Drug.
He left GlaxoWellcome in 1997 and joined Astra
in the UK as the local Head of Process Research &
Development. Over the next few years he developed the UK
group before taking over as VP at the Macclesfield Process R&D
group following the merger with Zeneca.
In 2002 David was made Global Vice President
of Process Research & Development. This group currently
consists of about 800 staff based on four sites; two in the UK
(Macclesfield and Loughborough), one in Södertälje, Sweden and one
in Bangalore, India. There is also a small sourcing group
based in Shanghai, China. In addition to his global role he
is also currently Site Manager of the AstraZeneca R&D
Charnwood, Chairman of the AstraZeneca India PL Board and Trustee
of the AstraZeneca Science Teaching Trust.
Outside of AstraZeneca, Dr Haywood sits on the
Enterprise Board of Loughborough University and the Board of
SEMTA.